Telomerase

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The maintenance of telomeres by the cellular ribonucleoprotein enzyme telomerase is of well-documented importance for cancer. Telomerase, a cellular reverse transcriptase that adds DNA to the ends of chromosomes, is reactivated or upregulated in the vast majority of advanced malignancies, and is thus an almost universal target for the treatment of human cancers. Most human tumors not only express telomerase but also have very short telomeres, whereas telomerase activity is absent or at lower levels in normal tissues which also have longer telomeres. This relationship between activation of telomerase activity and short telomeres in human malignancies makes the inhibition of telomerase a valuable target for cancer therapeutics. Importantly, the mode of action of telomerase inhibitors predicts minimal side effects on normal stem cells that can express telomerase. In summary, the growing literature of studies on human telomeres and telomerase highlights the complex interplay between signals emanating from dysfunctional telomeres and tumor suppressor pathways that regulate stem cell biology and how this may relate to both aging and cancer. A more complete understanding of these relationships should lead to more effective clinical trials.

Original languageEnglish (US)
Title of host publicationBrenner's Encyclopedia of Genetics
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages36-37
Number of pages2
ISBN (Electronic)9780080961569
ISBN (Print)9780123749840
DOIs
StatePublished - Feb 27 2013

Fingerprint

telomerase
Telomerase
telomeres
Telomere
neoplasms
Neoplasms
Stem cells
stem cells
Tumors
Stem Cells
Cytology
ribonucleoproteins
Ribonucleoproteins
RNA-directed DNA polymerase
RNA-Directed DNA Polymerase
Chromosomes
cell biology
Cell Biology
clinical trials
mechanism of action

Keywords

  • Cancer
  • Chromosomes
  • DNA
  • HTERT
  • Reverse transcriptase
  • Ribonucleoprotein
  • Senescence
  • Shelterin
  • Telomerase
  • Telomeres

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Shay, J. W. (2013). Telomerase. In Brenner's Encyclopedia of Genetics: Second Edition (pp. 36-37). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374984-0.01522-9

Telomerase. / Shay, J. W.

Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc., 2013. p. 36-37.

Research output: Chapter in Book/Report/Conference proceedingChapter

Shay, JW 2013, Telomerase. in Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc., pp. 36-37. https://doi.org/10.1016/B978-0-12-374984-0.01522-9
Shay JW. Telomerase. In Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc. 2013. p. 36-37 https://doi.org/10.1016/B978-0-12-374984-0.01522-9
Shay, J. W. / Telomerase. Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc., 2013. pp. 36-37
@inbook{450832bd97784041bb24e8c12a19a3eb,
title = "Telomerase",
abstract = "The maintenance of telomeres by the cellular ribonucleoprotein enzyme telomerase is of well-documented importance for cancer. Telomerase, a cellular reverse transcriptase that adds DNA to the ends of chromosomes, is reactivated or upregulated in the vast majority of advanced malignancies, and is thus an almost universal target for the treatment of human cancers. Most human tumors not only express telomerase but also have very short telomeres, whereas telomerase activity is absent or at lower levels in normal tissues which also have longer telomeres. This relationship between activation of telomerase activity and short telomeres in human malignancies makes the inhibition of telomerase a valuable target for cancer therapeutics. Importantly, the mode of action of telomerase inhibitors predicts minimal side effects on normal stem cells that can express telomerase. In summary, the growing literature of studies on human telomeres and telomerase highlights the complex interplay between signals emanating from dysfunctional telomeres and tumor suppressor pathways that regulate stem cell biology and how this may relate to both aging and cancer. A more complete understanding of these relationships should lead to more effective clinical trials.",
keywords = "Cancer, Chromosomes, DNA, HTERT, Reverse transcriptase, Ribonucleoprotein, Senescence, Shelterin, Telomerase, Telomeres",
author = "Shay, {J. W.}",
year = "2013",
month = "2",
day = "27",
doi = "10.1016/B978-0-12-374984-0.01522-9",
language = "English (US)",
isbn = "9780123749840",
pages = "36--37",
booktitle = "Brenner's Encyclopedia of Genetics",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Telomerase

AU - Shay, J. W.

PY - 2013/2/27

Y1 - 2013/2/27

N2 - The maintenance of telomeres by the cellular ribonucleoprotein enzyme telomerase is of well-documented importance for cancer. Telomerase, a cellular reverse transcriptase that adds DNA to the ends of chromosomes, is reactivated or upregulated in the vast majority of advanced malignancies, and is thus an almost universal target for the treatment of human cancers. Most human tumors not only express telomerase but also have very short telomeres, whereas telomerase activity is absent or at lower levels in normal tissues which also have longer telomeres. This relationship between activation of telomerase activity and short telomeres in human malignancies makes the inhibition of telomerase a valuable target for cancer therapeutics. Importantly, the mode of action of telomerase inhibitors predicts minimal side effects on normal stem cells that can express telomerase. In summary, the growing literature of studies on human telomeres and telomerase highlights the complex interplay between signals emanating from dysfunctional telomeres and tumor suppressor pathways that regulate stem cell biology and how this may relate to both aging and cancer. A more complete understanding of these relationships should lead to more effective clinical trials.

AB - The maintenance of telomeres by the cellular ribonucleoprotein enzyme telomerase is of well-documented importance for cancer. Telomerase, a cellular reverse transcriptase that adds DNA to the ends of chromosomes, is reactivated or upregulated in the vast majority of advanced malignancies, and is thus an almost universal target for the treatment of human cancers. Most human tumors not only express telomerase but also have very short telomeres, whereas telomerase activity is absent or at lower levels in normal tissues which also have longer telomeres. This relationship between activation of telomerase activity and short telomeres in human malignancies makes the inhibition of telomerase a valuable target for cancer therapeutics. Importantly, the mode of action of telomerase inhibitors predicts minimal side effects on normal stem cells that can express telomerase. In summary, the growing literature of studies on human telomeres and telomerase highlights the complex interplay between signals emanating from dysfunctional telomeres and tumor suppressor pathways that regulate stem cell biology and how this may relate to both aging and cancer. A more complete understanding of these relationships should lead to more effective clinical trials.

KW - Cancer

KW - Chromosomes

KW - DNA

KW - HTERT

KW - Reverse transcriptase

KW - Ribonucleoprotein

KW - Senescence

KW - Shelterin

KW - Telomerase

KW - Telomeres

UR - http://www.scopus.com/inward/record.url?scp=85043273452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043273452&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374984-0.01522-9

DO - 10.1016/B978-0-12-374984-0.01522-9

M3 - Chapter

AN - SCOPUS:85043273452

SN - 9780123749840

SP - 36

EP - 37

BT - Brenner's Encyclopedia of Genetics

PB - Elsevier Inc.

ER -